Clinical Trial Update: Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

View source ↗

Summary

A trial update evaluating the Genomic Grade Index (GGI) for feasibility in routine practice and its influence on treatment decisions for early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: Invasive Breast Cancer | Status: COMPLETED